Injection devices didn't start with GLP-1s
The pens used for semaglutide and tirzepatide today are the direct descendants of decades of injectable-drug delivery technology developed originally for insulin, not something invented alongside GLP-1 medications themselves. According to PubMed, a historical review of insulin delivery technology traces the arc from the original vial-and-syringe method used since insulin's first therapeutic use in 1921, through the introduction of the pen injector, to increasingly refined disposable and reusable pen designs developed over the following decades (Fry, Journal of Diabetes Science and Technology, 2012, DOI (external link)). The review notes that pen injectors emerged specifically to address the practical burdens of vial-and-syringe use — carrying multiple components, drawing up doses accurately, and the visibility and handling of a bare needle — and that device design has continuously evolved since to reduce user error and improve ease of use. GLP-1 pens inherited this design lineage directly, which is why the categories below will look familiar to anyone who's used an insulin pen.
Three general categories of injection devices
- Vial and syringe: the original method — medication is drawn up manually into a syringe from a vial before each injection. Still used today, notably for many compounded GLP-1 products.
- Manual dial-a-dose pens: a pre-filled, typically reusable or semi-reusable pen where the user attaches a needle, dials the desired dose on the pen, and manually inserts the needle and presses the plunger to inject. This style of device is often associated with the "KwikPen"-type design widely used across insulin products, and some GLP-1 formulations use a similar dial-based approach, particularly where a single pen needs to deliver a range of possible doses.
- Fully automatic single-dose auto-injectors: a pre-set, single-use (or single-dose) pen where the needle stays hidden throughout, and a single button press or press-and-hold action completes the entire injection automatically, with no dose dialing required. Many current GLP-1 weight-management and diabetes pens use this style for at least some doses in their lineup.
Benefits of auto-injectors compared to vial-and-syringe
- Substantially reduced dosing error risk. A pre-set auto-injector removes the need to calculate a draw-up volume from a vial's concentration — a step that, as covered in our guide on compounded dosing: vials vs. pens, is a meaningful source of potential error, particularly with compounded products where concentration can vary.
- No visible needle handling. The needle is hidden before, during, and after injection in most auto-injector designs, which reduces both needle-related anxiety and the risk of accidental needle-stick.
- Fewer steps, lower chance of a missed or incomplete step. Vial-and-syringe use involves multiple sequential steps (drawing air, inverting the vial, drawing the correct volume, expelling air bubbles, injecting) where a skipped or mishandled step can affect dose accuracy; an auto-injector reduces this to attaching (if needed), pressing, and holding.
- Improved portability and sterility management. Single-use auto-injectors avoid the need to carry and manage separate vials, syringes, and needles, and reduce reuse-related contamination risk.
Auto-injectors vs. manual dial pens: the real tradeoff
This isn't simply "auto-injectors are strictly better" — the two designs make different tradeoffs:
| Manual dial pens (KwikPen-style) | Auto-injectors | |
|---|---|---|
| Dose flexibility | Higher — a single pen can often deliver a range of doses by dialing | Lower — typically pre-set to one specific dose per pen, requiring a new pen for a different dose |
| Steps involved | More — attach needle, dial dose, manually insert and press | Fewer — often just remove cap, press, and hold |
| Needle visibility | Needle typically visible during attachment and injection | Needle typically hidden throughout |
| Best suited for | Situations needing dose flexibility within one device, such as certain titration stages | Simplicity and consistency once a specific dose is established |
| Common use case in GLP-1s | Often used where a single pen needs to support multiple titration steps | Often used for weight-management and later-stage maintenance dosing where the dose is more fixed |
Neither design is universally "better" — a manual dial pen offers more flexibility if your dose is still changing frequently, while an auto-injector offers more simplicity and fewer error-prone steps once your dose is stable. Which one you have often depends on your specific medication, brand, and titration stage rather than a choice you make yourself, though it's a reasonable thing to ask your prescriber or pharmacist about if you have a preference.
Practical technique still matters either way
Regardless of device type, proper technique — priming when required, confirming the correct dose or pen strength, and consistent site rotation — remains essential. See our guide on pen types and injection technique for device-agnostic best practices.
The bottom line
GLP-1 auto-injectors are the product of a century of injection device refinement inherited from insulin delivery technology, not a GLP-1-specific invention. Compared to vial-and-syringe dosing, they meaningfully reduce steps and error risk; compared to manual dial pens, they trade some dose flexibility for simplicity — which device you use often depends on your specific medication and where you are in treatment, rather than being a strictly "better vs. worse" choice.